{"entity":{"type":"insider","cik":"0001838671","url":"/insider/0001838671","json_url":"/insider/0001838671.json","name":"Trigilio Jeffrey","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":13,"first":"2021-01-14","last":"2023-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Trigilio Jeffrey","source":"filing","n_filings":13,"first_seen":"2021-01-14","last_seen":"2023-12-22"}],"transactions":[{"id":7838780,"accession":"0000950170-23-072754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-072754","line_url":"/filing/0000950170-23-072754#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1920.0,"shares_display":"1,920","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":16320.0,"total_display":"16,320.00","total_whole":"16,320","shares_owned_after":83919.0,"shares_owned_after_display":"83,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-22","scope":"insider"},{"id":8282514,"accession":"0000950170-23-071985","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-071985","line_url":"/filing/0000950170-23-071985#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398.0,"shares_display":"398","price_per_share":8.22,"price_display":"8.22","price_state":"stated","total_value":3271.56,"total_display":"3,271.56","total_whole":"3,272","shares_owned_after":85839.0,"shares_owned_after_display":"85,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-20","scope":"insider"},{"id":7801454,"accession":"0000950170-23-070143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-070143","line_url":"/filing/0000950170-23-070143#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1926.0,"shares_display":"1,926","price_per_share":7.81,"price_display":"7.81","price_state":"stated","total_value":15042.06,"total_display":"15,042.06","total_whole":"15,042","shares_owned_after":86237.0,"shares_owned_after_display":"86,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-13","scope":"insider"},{"id":8250778,"accession":"0000950170-23-029158","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-029158","line_url":"/filing/0000950170-23-029158#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399.0,"shares_display":"399","price_per_share":12.94,"price_display":"12.94","price_state":"stated","total_value":5163.06,"total_display":"5,163.06","total_whole":"5,163","shares_owned_after":85823.0,"shares_owned_after_display":"85,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-21","scope":"insider"},{"id":8108347,"accession":"0000950170-23-027985","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-027985","line_url":"/filing/0000950170-23-027985#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":319.0,"shares_display":"319","price_per_share":13.11,"price_display":"13.11","price_state":"stated","total_value":4182.09,"total_display":"4,182.09","total_whole":"4,182","shares_owned_after":86222.0,"shares_owned_after_display":"86,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-14","scope":"insider"},{"id":7987621,"accession":"0000899243-23-013358","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-013358","line_url":"/filing/0000899243-23-013358#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399.0,"shares_display":"399","price_per_share":8.76,"price_display":"8.76","price_state":"stated","total_value":3495.24,"total_display":"3,495.24","total_whole":"3,495","shares_owned_after":86541.0,"shares_owned_after_display":"86,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":8695381,"accession":"0000950170-23-022548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-022548","line_url":"/filing/0000950170-23-022548#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":347.0,"shares_display":"347","price_per_share":8.78,"price_display":"8.78","price_state":"stated","total_value":3046.66,"total_display":"3,046.66","total_whole":"3,047","shares_owned_after":86940.0,"shares_owned_after_display":"86,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-12","filed_date":"2023-05-16","scope":"insider"},{"id":8576200,"accession":"0000950170-23-013702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-013702","line_url":"/filing/0000950170-23-013702#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398.0,"shares_display":"398","price_per_share":10.71,"price_display":"10.71","price_state":"stated","total_value":4262.58,"total_display":"4,262.58","total_whole":"4,263","shares_owned_after":87287.0,"shares_owned_after_display":"87,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-20","scope":"insider"},{"id":8620151,"accession":"0000899243-23-011298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-011298","line_url":"/filing/0000899243-23-011298#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318.0,"shares_display":"318","price_per_share":10.22,"price_display":"10.22","price_state":"stated","total_value":3249.96,"total_display":"3,249.96","total_whole":"3,250","shares_owned_after":87685.0,"shares_owned_after_display":"87,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-12","filed_date":"2023-04-14","scope":"insider"},{"id":8528082,"accession":"0000899243-23-009718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-009718","line_url":"/filing/0000899243-23-009718#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399.0,"shares_display":"399","price_per_share":11.32,"price_display":"11.32","price_state":"stated","total_value":4516.68,"total_display":"4,516.68","total_whole":"4,517","shares_owned_after":88003.0,"shares_owned_after_display":"88,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-27","scope":"insider"},{"id":4868719,"accession":"0000899243-21-040454","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-040454","line_url":"/filing/0000899243-21-040454#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":2250.0,"shares_owned_after_display":"2,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-18","scope":"insider"},{"id":5276767,"accession":"0000899243-21-035417","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-035417","line_url":"/filing/0000899243-21-035417","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":28.476884,"price_display":"28.48","price_state":"stated","total_value":427153.26,"total_display":"427,153.26","total_whole":"427,153","shares_owned_after":2250.0,"shares_owned_after_display":"2,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-08","filed_date":"2021-09-09","scope":"insider","n_lines":2},{"id":4507630,"accession":"0000899243-21-002047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-002047","line_url":"/filing/0000899243-21-002047#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Management, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838671","owner_name":"Trigilio Jeffrey","owner_display_name":"Trigilio Jeffrey","owner_url":"/insider/0001838671","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2250.0,"shares_display":"2,250","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":47250.0,"total_display":"47,250.00","total_whole":"47,250","shares_owned_after":2250.0,"shares_owned_after_display":"2,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001789972","name":"Cullinan Oncology, Inc.","url":"/issuer/0001789972","role":"Officer (Chief Financial Officer)","n_filings":13,"first_seen":"2021-01-14","last_seen":"2023-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001838671","retrieved_at":"2026-08-24T15:43:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}